New Product Planning Lead (maternity cover)

The position

This is a temporary position of 12 months to cover a maternity leave, where you will act as NPP Lead in theCardiovascular Disease and Emerging Therapy Areas (CETA) NPP team, with expected starting date 1stDecember . Your key tasks will be to be commercially responsible for R&D projects across the CETA portfolio, workingwithin the project team of a drug candidate to develop the target product profile and early positioning,collecting primary and secondary data on market conditions and preference shares, and shaping insights intoactionable commercial recommendations. Some of your responsibilities that you will find:• Drive commercial assessments to enable key project decisions and aligning these though the EarlyCommercial Team.• Provide commercial input for the Product Development Plan and creating financial valuations of assetsas they prepare to enter Phase 2 clinical development.• Drive portfolio assessments and development of commercial Guidance to Research, as well ascontributing to the annual value assessment of the late-stage project portfolio.• Coordinate and collaborate with internal colleagues from Research & Development, Commercial,Global Evidence & Patient Access, Strategic Finance, and Product Supply. You will work in a globalcontext but interact primarily with headquarter functions. You should expect up to 10 travel days per year. Qualifications • A Master’s degree in business or economics combined with extensive skills in natural science, or ascientific Master’s degree combined with strong commercial experience• Minimum 2 years’ experience working in a pharmaceutical company.• Experience from working in a New Product Planning team. Some experience within Commercial BrandTeams will be a plus.• Experience with doing financial valuations incl. DCF modelling.• Any expertise in a key function in the drug development value chain, e.g., R&D, Medical Affairs,Regulatory Affairs, Marketing, will be highly appreciated. On the personal side, we expect you to have excellent interpersonal skills, as this position requires you to workacross multiple stakeholders in the company. You have a track record of delivering in high quality and findingnew ways of achieving goals. You are self-driven, proactive and innovative and inspire ways of working smarter.You strive to take team performance to a higher level and you have demonstrated the ability to workindividually as well as in a team on multiple projects in parallel. Excellent written and spoken English with strong communication skills will be required.Please note that the pharmaceutical experience is mandatory for this role. Only candidates with experiencefrom working in a pharmaceutical company will be considered. Physical presence is required in our offices inCopenhagen (Søborg), Denmark. Only candidates who are willing to commute to the Copenhagen Area will beconsidered About the department The CETA Early Portfolio & Insights (EP&I) functional area sets the commercial direction for Novo Nordisk’sfuture drug portfolio within CETA, including also Chronic Kidney Disease, Alzheimer’s disease, and MASH/liverdisease.The EP&I area consists of departments covering New Product Planning, Competitive Intelligence, CustomerInsights, and Forecasting. Within the EP&I functional area, the NPP team holds the commercial responsibilityfor the early portfolio of projects across CETA. In the NPP department you will join a team of seven experiencedbusiness professionals like yourself and you will work in collaboration with the broader NPP team across all ofNovo Nordisk’s strategic areas.You will report to the Vice President of CETA EP&I, Head of New Product Planning. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamicindustry, and we know that what got us to where we are today is not necessarily what will make us successfulin the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection.We never shy away from opportunities to develop, we seize them. From research and development, through tomanufacturing, marketing and sales – we’re all working to move the needle on patient care.